Nurix Therapeutics Inc (NRIX) Ownership

16.73 ↑0.00 (0.00%)
As of June 7, 2024, 3:59pm EST.

Institutional Ownership

BlackRock Inc is the biggest individual institutional holder of Nurix Therapeutics Inc (NRIX), owning a total of 4.6 million shares. Combined, the top 32 institutional holders of NRIX own 83.63% of the company with a total of 48.2 million shares.

In the latest ownership report on March 31st 2024, the top 32 institutional holders decreased their combined ownership of NRIX by 1.4 million shares. 2 institutions bought 1,654,082 total additional shares and increased their ownership by an average of 30.28%. However 8 institutions sold 3,076,971 total shares and decreased their ownership by an average of 16.41%.

Overall this is a negative sign as the number of shares owned by the top 20 institutional holders of Nurix Therapeutics Inc decreased by a net total of -1,422,889 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Redmile Group, LLC7.341%57.364%4,483,0161,634,1892024-03-31
Baker Bros Advisors LP6.357%0.000%3,882,12502024-03-31
Deep Track Capital, LP4.909%0.000%2,997,83002024-03-31
ARK Investment Management LLC4.316%-17.517%2,635,338-559,6612024-03-31
Vanguard Group Inc4.232%-0.531%2,584,300-13,7972024-03-31
T. Rowe Price Associates, Inc.3.596%-8.109%2,196,169-193,7972024-03-31
Wasatch Advisors LP2.025%-55.023%1,236,753-1,512,9922024-03-31
Bain Capital Life Sciences Investors, LLC1.854%-37.879%1,132,397-690,4862024-03-31
Dimensional Fund Advisors, Inc.1.583%-3.359%966,453-33,5912024-03-31
Candriam Luxembourg S.C.A.1.461%-2.832%892,110-26,0002024-03-31
Pictet Asset Manangement SA1.190%-6.030%726,941-46,6472024-03-31
Charles Schwab Investment Management Inc1.052%3.197%642,19019,8932024-03-31

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
BlackRock Inc7.604%2.770%4,643,736125,1822023-12-31
Redmile Group, LLC7.341%57.364%4,483,0161,634,1892024-03-31
Baker Bros Advisors LP6.357%0.000%3,882,12502024-03-31
Morgan Stanley - Brokerage Accounts5.134%1,137.130%3,135,0372,881,6242023-12-31
Deep Track Capital, LP4.909%0.000%2,997,83002024-03-31
Wasatch Advisors Inc.5.624%-22.860%2,749,745-814,8712023-12-31
ARK Investment Management LLC4.316%-17.517%2,635,338-559,6612024-03-31
Vanguard Group Inc4.232%-0.531%2,584,300-13,7972024-03-31
T. Rowe Price Associates, Inc.3.596%-8.109%2,196,169-193,7972024-03-31
TRV GP III, LLC4.078%0.000%1,922,54902022-06-30
Wasatch Advisors LP2.025%-55.023%1,236,753-1,512,9922024-03-31
Boxer Capital LLC2.505%0.000%1,224,89202023-09-30
Bain Capital Life Sciences Investors, LLC1.854%-37.879%1,132,397-690,4862024-03-31
Geode Capital Management, LLC1.769%3.371%1,080,52335,2382023-12-31
T. Rowe Price Investment Management,Inc.2.099%0.000%992,428992,4282022-09-30
Dimensional Fund Advisors, Inc.1.583%-3.359%966,453-33,5912024-03-31
State Street Corporation1.509%-48.067%921,322-852,7462023-12-31
Candriam Luxembourg S.C.A.1.461%-2.832%892,110-26,0002024-03-31
Soleus Capital Management, L.P.1.678%0.000%814,000814,0002023-09-30
Pictet Asset Manangement SA1.190%-6.030%726,941-46,6472024-03-31
TCG Crossover Management, LLC1.175%0.000%717,654717,6542023-12-31
Affinity Asset Advisors, LLC1.130%176.045%690,112440,1122023-12-31
Foresite Capital Management IV, LLC1.436%-34.309%677,143-353,6552022-06-30
Millennium Management LLC1.329%39.606%644,411182,8192023-06-30
Charles Schwab Investment Management Inc1.052%3.197%642,19019,8932024-03-31
Goldman Sachs Group Inc0.923%55.092%563,800200,2742023-12-31
Dafna Capital Management LLC1.139%0.000%556,69502023-09-30
Bank of America Corp1.118%-7.070%546,450-41,5752023-09-30
Nuveen Asset Management, LLC0.874%-19.509%533,865-129,3952023-12-31
Deutsche Bank AG0.826%2,473.130%504,205484,6102023-12-31
Northern Trust Corp0.902%2.849%440,85212,2102023-09-30
FMR Inc0.859%-53.735%416,613-483,8752023-06-30

Mutual Fund Ownership

ARK Genomic Revolution ETF is the biggest individual fund holder of Nurix Therapeutics Inc (NRIX), owning a total of 2.6 million shares. Combined, the top 36 mutual fund holders of NRIX own 49.52% of the company with a total of 28.2 million shares.

In the latest ownership report on April 30th 2024, the top 36 fund holders increased their combined ownership of NRIX by 2.1 million shares. 6 funds bought 2,143,518 total additional shares and increased their ownership by an average of 9.36%. However 3 funds sold 57,989 total shares and decreased their ownership by an average of 1.31%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Nurix Therapeutics Inc increased by a net total of 2,085,529 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
ARK Genomic Revolution ETF4.316%0.000%2,635,72202024-04-30
Vanguard Total Stock Mkt Idx Inv3.051%30.149%1,863,179431,6002024-04-30
SPDR® S&P Biotech ETF2.688%-2.857%1,641,705-48,2852024-04-30
iShares Russell 2000 ETF1.811%-0.789%1,105,886-8,7892024-04-30
Vanguard Institutional Extnd Mkt Idx Tr1.334%18.577%814,877127,6652024-04-30
BlackRock Health Sciences Opps Inv A1.015%0.000%619,557619,5572024-04-30
Belfius Equities Cure C Cap0.945%7.448%577,09640,0002024-04-30
Xtrackers MSCI World Swap ETF 1C0.881%0.000%537,680537,6802024-04-30
iShares Russell 2000 Value ETF0.724%0.000%442,26902024-04-30
BlackRock Health Sciences Term Trust0.634%0.000%387,016387,0162024-04-30
iShares Biotechnology ETF0.549%-0.272%335,147-9152024-04-30
State St Russell Sm/Mid Cp® Indx NL Cl C0.482%0.000%294,51302024-04-30

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
ARK Genomic Revolution ETF4.316%0.000%2,635,72202024-04-30
ARK Genomic Revolution4.274%-17.542%2,610,055-555,2742024-03-31
Vanguard Total Stock Mkt Idx Inv3.051%30.149%1,863,179431,6002024-04-30
SPDR® S&P Biotech ETF2.688%-2.857%1,641,705-48,2852024-04-30
Vanguard Instl Ttl Stck Mkt Idx Tr3.240%29.436%1,571,546357,4002023-03-31
Eventide Healthcare & Life Sciences I2.448%-38.289%1,154,000-716,0002022-06-30
T. Rowe Price New Horizons1.868%-13.738%1,140,710-181,6732024-03-31
US Small-Cap Growth II Equity Comp1.868%-13.738%1,140,710-181,6732024-03-31
iShares Russell 2000 ETF1.811%-0.789%1,105,886-8,7892024-04-30
Wasatch Small Cap Growth Investor1.852%-2.514%898,101-23,1602023-09-30
Wasatch Ultra Growth1.428%-9.689%872,052-93,5582024-03-31
Vanguard Institutional Extnd Mkt Idx Tr1.334%18.577%814,877127,6652024-04-30
Wasatch Small Cap Value1.430%29.273%702,910159,1682023-12-31
BlackRock Health Sciences Opps Inv A1.015%0.000%619,557619,5572024-04-30
Vanguard Extended Market Index Investor1.278%-0.029%616,077-1812023-08-31
UBS: US Equity Small Cap Growth1.205%0.000%589,17602023-09-30
Belfius Equities Cure C Cap0.945%7.448%577,09640,0002024-04-30
Xtrackers MSCI World Swap ETF 1C0.881%0.000%537,680537,6802024-04-30
Candriam Global Equities Oncology0.880%-4.617%537,096-26,0002024-03-31
TIAA-CREF Quant Small-Cap Equity Instl1.026%20.000%501,61083,6002024-01-31
Fidelity Small Cap Index0.800%1.569%488,3497,5442024-02-29
Xtrackers S&P Global Infra Swap ETF 1C0.792%0.000%483,68802023-12-31
Fidelity® Small Cap Index0.940%1.146%456,1115,1682023-10-31
iShares Russell 2000 Value ETF0.724%0.000%442,26902024-04-30
Pictet-Biotech P USD0.671%-0.953%409,437-3,9412024-01-31
T. Rowe Price Small-Cap Value0.828%-30.260%390,408-169,4002022-09-30
BlackRock Health Sciences Term Trust0.634%0.000%387,016387,0162024-04-30
Fidelity® Select Biotechnology0.756%0.000%366,64602023-08-31
Pictet-Global Megatrend Sel I USD0.741%5.347%364,18518,4832023-12-31
Candriam Eqs L Biotech C USD Cap0.581%0.000%354,99202024-03-31
Wasatch Micro Cap0.717%27.338%352,48275,6732023-12-31
iShares Biotechnology ETF0.549%-0.272%335,147-9152024-04-30
Nuveen Quant Small Cap Equity Instl0.501%-38.987%306,050-195,5602024-02-29
Nuveen Quant Small Cap Equity R60.501%0.000%306,05002024-03-31
State St Russell Sm/Mid Cp® Indx NL Cl C0.482%0.000%294,51302024-04-30
Schwab Small-Cap Equity0.467%6.284%284,88916,8432024-03-31

Discussions

Please log in or register to share your thoughts.